Inhibitors of apoptosis proteins in experimental benign prostatic hyperplasia: effects of serenoa repens, selenium and lycopene.
about
Modern extraction techniques and their impact on the pharmacological profile of Serenoa repens extracts for the treatment of lower urinary tract symptomsApoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic HyperplasiaMedical perspective in testicular ischemia-reperfusion injuryConnections between lower urinary tract symptoms related to benign prostatic enlargement and metabolic syndrome with its components: a systematic review and meta-analysis.Management of Benign Prostatic Hyperplasia: Could Dietary Polyphenols Be an Alternative to Existing Therapies?Metabolic syndrome and prostatic disease: potentially role of polyphenols in preventive strategies. A review.Does an asymmetric lobe in digital rectal examination include any risk for prostate cancer? results of 1495 biopsies.Survivin and NAIP in Human Benign Prostatic Hyperplasia: Protective Role of the Association of Serenoa repens, Lycopene and Selenium from the Randomized Clinical Study.Letter to the editorResponse to: Russo A, Capogrosso P, La Croce G, et al. Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia. Expert Opin Drug Saf. 2016 Jun;1:1-10.Inhibitory effect of diosgenin on experimentally induced benign prostatic hyperplasia in rats.Relationship between non-alcoholic fatty liver disease and benign prostatic hyperplasia/lower urinary tract symptoms: new insights from an Italian cross-sectional study.The effect of pomegranate fruit extract on testosterone-induced BPH in rats.Effect ofSerenoa Repenson Oxidative Stress, Inflammatory and Growth Factors in Obese Wistar Rats with Benign Prostatic Hyperplasia
P2860
Q21256691-14D10765-A3FC-453E-A8C2-E552478A9B1DQ26741226-957931A5-5A2F-4ABA-BCD1-180575B11950Q33724234-C733B3B0-C3F7-43A6-B259-2DCD8F126FE1Q38546659-FD6D40D5-8CFE-4EE9-B518-58BC714FB67DQ38786798-5E8760EF-5363-4DB9-88FD-96CE72068246Q38861273-8DB72B28-9117-4903-BC85-C275AE6AA0D2Q39451058-7C7A6AB1-5703-4F48-AEAB-6A9C5E0FDE48Q41882420-74F2F3E8-314B-4EDE-AC67-42814F6B929AQ50491068-21BC278B-60A3-41A0-AC16-4B70670BA62EQ51281994-6EEB9C38-F957-44B8-9C25-3430D50F99B8Q53084606-F8C72576-F28D-4BE4-B66F-F15ADFB32743Q53635536-BE570C0E-84B1-4D48-B8EB-8A7380041FF9Q58865104-B0BA8819-0788-41AE-AEFB-E7EA780A4E07
P2860
Inhibitors of apoptosis proteins in experimental benign prostatic hyperplasia: effects of serenoa repens, selenium and lycopene.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Inhibitors of apoptosis protei ...... repens, selenium and lycopene.
@en
type
label
Inhibitors of apoptosis protei ...... repens, selenium and lycopene.
@en
prefLabel
Inhibitors of apoptosis protei ...... repens, selenium and lycopene.
@en
P2093
P2860
P50
P356
P1476
Inhibitors of apoptosis protei ...... repens, selenium and lycopene.
@en
P2093
Alessandra Bitto
Domenica Altavilla
Francesco Squadrito
Gabriele Pizzino
Giorgio Ivan Russo
Letteria Minutoli
Mariagrazia Rinaldi
Natasha Irrera
Sebastiano Cimino
P2860
P2888
P356
10.1186/1423-0127-21-19
P577
2014-03-10T00:00:00Z
P5875
P6179
1023326894